Bill > HR7497

This bill, titled the "Make Medicine Affordable Act", aims to lower drug prices through several key provisions: 1. It establishes a Drug Price Negotiation Program to negotiate maximum fair prices for certain high-priced single source drugs under Medicare Parts B and D. The Secretary will select a list of negotiation-eligible drugs, negotiate maximum fair prices with manufacturers, and apply those prices to Medicare payments. 2. It imposes an excise tax on manufacturers of selected drugs during periods of non-compliance with the negotiation process. 3. It requires manufacturers of certain drugs covered under Medicare Part B and Part D to pay rebates if their prices increase faster than inflation. 4. It redesigns the Medicare Part D benefit structure, including lowering the beneficiary coinsurance rate and establishing a monthly cost-sharing cap for beneficiaries. 5. It prohibits implementation of a rule that would have eliminated certain anti-kickback statute safe harbors related to prescription drug rebates. 6. It requires coverage of certain insulin products and adult vaccines under Medicare, Medicaid, CHIP, and private insurance plans with reduced or eliminated cost-sharing for beneficiaries. Overall, the bill aims to lower drug prices and out-of-pocket costs for Medicare and other beneficiaries, particularly for insulin and vaccines, through a combination of price negotiation, inflation rebates, benefit redesign, and coverage requirements.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/7497/all-info